精神分裂-话题@MedSci

#精神分裂#

253篇内容 | 5080人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1404118, encodeId=ce8b1404118ea, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Lancet：32种常见抗精神分裂药物的疗效及不良事件差异研究, objectType=article, longId=179384, objectId=0a851e938485, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a851e938485, replyNumber=0, likeNumber=104, createdTime=2019-09-15, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a851e938485, moduleTitle=Lancet：32种常见抗精神分裂药物的疗效及不良事件差异研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a851e938485)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404117, encodeId=afe1140411e2e, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Cell ：精神分裂症中诡异的小清蛋白神经元, objectType=article, longId=178834, objectId=31451e88347b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31451e88347b, replyNumber=0, likeNumber=88, createdTime=2019-09-06, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31451e88347b, moduleTitle=Cell ：精神分裂症中诡异的小清蛋白神经元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31451e88347b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404116, encodeId=19e3140411656, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=CELL：遗传性精神分裂症认知功能障碍的长期改善, objectType=article, longId=178491, objectId=0e9d1e849172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9d1e849172, replyNumber=0, likeNumber=76, createdTime=2019-09-02, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9d1e849172, moduleTitle=CELL：遗传性精神分裂症认知功能障碍的长期改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9d1e849172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404115, encodeId=29ac14041153c, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Alkermes的精神分裂症候选药物ALKS 3831将扩大向FDA的营销申请，以用于治疗I型双相情感障碍, objectType=article, longId=175616, objectId=69861e5616fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69861e5616fe, replyNumber=0, likeNumber=81, createdTime=2019-07-18, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69861e5616fe, moduleTitle=Alkermes的精神分裂症候选药物ALKS 3831将扩大向FDA的营销申请，以用于治疗I型双相情感障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69861e5616fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404114, encodeId=3ade14041141c, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Neuron：自闭症或精神分裂，可能是大脑连接不足所致, objectType=article, longId=166155, objectId=57b116615515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b116615515, replyNumber=0, likeNumber=67, createdTime=2019-05-17, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b116615515, moduleTitle=Neuron：自闭症或精神分裂，可能是大脑连接不足所致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57b116615515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404113, encodeId=82f51404113ea, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=治疗精神分裂症：SEP-363856已获FDA突破性疗法认定, objectType=article, longId=165923, objectId=db6a165923d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db6a165923d4, replyNumber=0, likeNumber=70, createdTime=2019-05-14, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db6a165923d4, moduleTitle=治疗精神分裂症：SEP-363856已获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db6a165923d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404112, encodeId=66361404112e0, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=JAMA Psychiatry：硝普钠并不能快速改善精神分裂症的病情, objectType=article, longId=165673, objectId=6ff01656e3e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ff01656e3e4, replyNumber=0, likeNumber=69, createdTime=2019-05-10, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ff01656e3e4, moduleTitle=JAMA Psychiatry：硝普钠并不能快速改善精神分裂症的病情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ff01656e3e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404111, encodeId=dc17140411196, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=首发精神分裂症的治疗：联用西酞普兰, objectType=article, longId=164442, objectId=543f16444283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=543f16444283, replyNumber=0, likeNumber=48, createdTime=2019-04-18, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=543f16444283, moduleTitle=首发精神分裂症的治疗：联用西酞普兰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=543f16444283)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404110, encodeId=b0241404110d3, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=SCI REP：长期使用氯氮平对精神分裂症患者的骨密度具有保护作用, objectType=article, longId=161976, objectId=438d1619e667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=438d1619e667, replyNumber=0, likeNumber=69, createdTime=2019-03-11, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=438d1619e667, moduleTitle=SCI REP：长期使用氯氮平对精神分裂症患者的骨密度具有保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=438d1619e667)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404109, encodeId=f06514041099a, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=2019 IPS临床实践指南：儿童和青少年精神分裂的管理, objectType=article, longId=161356, objectId=9e23161356ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e23161356ad, replyNumber=0, likeNumber=28, createdTime=2019-03-01, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e23161356ad, moduleTitle=2019 IPS临床实践指南：儿童和青少年精神分裂的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e23161356ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404108, encodeId=49cf14041085a, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Brain Behav Immun：弓形虫可能会增加精神分裂症风险, objectType=article, longId=160513, objectId=e5451605136e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5451605136e, replyNumber=0, likeNumber=62, createdTime=2019-02-21, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5451605136e, moduleTitle=Brain Behav Immun：弓形虫可能会增加精神分裂症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5451605136e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404107, encodeId=b0d6140410e9f, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=JAMA Psychiatry：科学家发现精神分裂相关基因位点, objectType=article, longId=159859, objectId=71011598595e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71011598595e, replyNumber=0, likeNumber=46, createdTime=2019-02-14, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71011598595e, moduleTitle=JAMA Psychiatry：科学家发现精神分裂相关基因位点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71011598595e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404106, encodeId=e26b1404106c9, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Schizophrenia Research：发现精神分裂症患者期待愉快情绪损伤, objectType=article, longId=157368, objectId=62d915e3684a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62d915e3684a, replyNumber=0, likeNumber=73, createdTime=2019-01-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62d915e3684a, moduleTitle=Schizophrenia Research：发现精神分裂症患者期待愉快情绪损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62d915e3684a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404105, encodeId=f87b1404105be, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Sci Rep：缺乏维D，新生儿成年后患精神分裂症的风险增加44%, objectType=article, longId=155599, objectId=541615559943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=541615559943, replyNumber=0, likeNumber=96, createdTime=2018-12-12, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=541615559943, moduleTitle=Sci Rep：缺乏维D，新生儿成年后患精神分裂症的风险增加44%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=541615559943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404104, encodeId=2ad41404104ca, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=CNS Drugs：精神分裂症患者的社会心理功能，氯氮平PK其他抗精神病药物, objectType=article, longId=151724, objectId=c889151e24f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c889151e24f0, replyNumber=0, likeNumber=81, createdTime=2018-10-25, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c889151e24f0, moduleTitle=CNS Drugs：精神分裂症患者的社会心理功能，氯氮平PK其他抗精神病药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c889151e24f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404103, encodeId=224f140410302, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=西安杨森宣布治疗精神分裂症的长效针剂善妥达在中国上市, objectType=article, longId=148860, objectId=fc1b1488604d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc1b1488604d, replyNumber=0, likeNumber=86, createdTime=2018-09-16, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc1b1488604d, moduleTitle=西安杨森宣布治疗精神分裂症的长效针剂善妥达在中国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc1b1488604d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404102, encodeId=8f9b1404102a4, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Pharmacoeconomics：药物治疗不依从是否增加精神分裂症治疗成本？, objectType=article, longId=148273, objectId=eef81482e377, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eef81482e377, replyNumber=0, likeNumber=79, createdTime=2018-09-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eef81482e377, moduleTitle=Pharmacoeconomics：药物治疗不依从是否增加精神分裂症治疗成本？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eef81482e377)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404101, encodeId=7f54140410194, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Ind Psychiatry J：精神分裂症和慢性阻塞性肺病患者的生活质量, objectType=article, longId=146398, objectId=354714639831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=354714639831, replyNumber=0, likeNumber=59, createdTime=2018-08-13, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=354714639831, moduleTitle=Ind Psychiatry J：精神分裂症和慢性阻塞性肺病患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=354714639831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404100, encodeId=a6b4140410034, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=FDA批准PERSERIS（利培酮）延长释放悬浮液治疗成人精神分裂症, objectType=article, longId=145540, objectId=3f6e145540e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f6e145540e6, replyNumber=0, likeNumber=69, createdTime=2018-08-01, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f6e145540e6, moduleTitle=FDA批准PERSERIS（利培酮）延长释放悬浮液治疗成人精神分裂症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f6e145540e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1404099, encodeId=aba314040999d, content=<a href='/topic/show?id=7366e6493be' target=_blank style='color:#2F92EE;'>#精神分裂#</a>, objectTitle=Schizophr Res：一种新的精神分裂症持续性阴性症状评估标准, objectType=article, longId=144659, objectId=446e14465994, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=446e14465994, replyNumber=0, likeNumber=85, createdTime=2018-07-19, rootId=0, userName=bnurmamat, userId=bfe92444551, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=446e14465994, moduleTitle=Schizophr Res：一种新的精神分裂症持续性阴性症状评估标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=446e14465994)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

精神分裂

2020-05-29

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Lancet：32种常见抗精神分裂药物的疗效及不良事件差异研究

2019-09-15

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Cell ：精神分裂症中诡异的小清蛋白神经元

2019-09-06

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

CELL：遗传性精神分裂症认知功能障碍的长期改善

2019-09-02

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Alkermes的精神分裂症候选药物ALKS 3831将扩大向FDA的营销申请，以用于治疗I型双相情感障碍

2019-07-18

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Neuron：自闭症或精神分裂，可能是大脑连接不足所致

2019-05-17

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

治疗精神分裂症：SEP-363856已获FDA突破性疗法认定

2019-05-14

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

JAMA Psychiatry：硝普钠并不能快速改善精神分裂症的病情

2019-05-10

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

首发精神分裂症的治疗：联用西酞普兰

2019-04-18

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

SCI REP：长期使用氯氮平对精神分裂症患者的骨密度具有保护作用

2019-03-11

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

2019 IPS临床实践指南：儿童和青少年精神分裂的管理

2019-03-01

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Brain Behav Immun：弓形虫可能会增加精神分裂症风险

2019-02-21

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

JAMA Psychiatry：科学家发现精神分裂相关基因位点

2019-02-14

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Schizophrenia Research：发现精神分裂症患者期待愉快情绪损伤

2019-01-07

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Sci Rep：缺乏维D，新生儿成年后患精神分裂症的风险增加44%

2018-12-12

智慧医人 (审核中...)

前往app查看评论内容

#精神分裂#

CNS Drugs：精神分裂症患者的社会心理功能，氯氮平PK其他抗精神病药物

2018-10-25

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

西安杨森宣布治疗精神分裂症的长效针剂善妥达在中国上市

2018-09-16

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Pharmacoeconomics：药物治疗不依从是否增加精神分裂症治疗成本？

2018-09-07

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

Ind Psychiatry J：精神分裂症和慢性阻塞性肺病患者的生活质量

2018-08-13

heli0118 (审核中...)

前往app查看评论内容

#精神分裂#

FDA批准PERSERIS（利培酮）延长释放悬浮液治疗成人精神分裂症

2018-08-01

bnurmamat (审核中...)

前往app查看评论内容

#精神分裂#

Schizophr Res：一种新的精神分裂症持续性阴性症状评估标准

2018-07-19

科室
- - 订阅+
  - 更多科室
工具
服务